LMAT News and Press, LeMaitre Vascular Inc. From 07/29/21

LeMaitre Vascular (NASDAQ:LMAT): Q2 GAAP EPS of $0.40 beats by $0.05. Revenue of $40.7M (+63.8% Y/Y) in-line. Press Release For further details see: LeMaitre Vascular EPS beats by $0.05, revenue in-line

BURLINGTON, Mass., July 29, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2021 results, announced an $0.11/share quarterly dividend and provided guidance. Q2 2021 Financial Results Sales of $4...

The CPI-W increased 6.1% year-over-year in June. Healthcare is historically a strong performer later in the business cycle. The healthcare sector is improving in our large cap sector ranking. Top scoring healthcare stocks worth adding to your watch list. For further deta...

BURLINGTON, Mass., July 15, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2021 financial results on Thursday, July 29, 2021, after the market close. The company has scheduled a conference call for 5:00 PM ET the same d...

LeMaitre Vascular ([[LMAT]] -8.3%) looks set to record its biggest one-day loss since November after the company announced a common stock offering of 1M, expecting to raise ~$54.5M in gross proceeds.Yesterday’s announcement coincided with the preliminary Q2 2021 numbers disclosed ...

LeMaitre Vascular (LMAT) has priced its public offering of 1M common shares at $54.50/share, for expected gross proceeds of ~$54.5M.Underwriters' over-allotment is an additional 150K shares. Net proceeds will be used to repay outstanding borrowings, for general corporate purposes, working cap...

BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at a public offering price of ...

BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares to be sold in ...

BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced preliminary unaudited results for the quarter ended June 30, 2021. Q2 2021 Preliminary Results Net Sa...

When a company initiates a huge dividend increase, its investors typically receive the news warmly. But it's always important to look deeper -- especially with a large payout rise. Recently, LeMaitre Vascular (NASDAQ: LMAT) announced it was increasing its quarterly dividend from...